Cardiogenic Shock
Study results from Erasmus Medical Center, Department of Cardiology provide new insights into cardiogenic shock
Published in Cardiovascular Business Week, September 15th, 2009
Scientists discuss in 'Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials' new findings in cardiogenic shock. "Studies have compared safety and efficacy of percutaneous left ventricular assist devices (LVADs) with intra-aortic balloon pump (IABP) counterpulsation in patients with cardiogenic shock. We performed a meta-analysis of controlled trials to evaluate potential benefits of percutaneous LVAD on haemodynamics and 30-day survival," scientists writing in the European Heart Journal report.
"Two independent investigators searched Medline, Embase,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Abiomed, Inc.
First Post-Trial AbioCor Patient Passes Away - Artificial Organs
American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon - Atrial Fibrillation
September 2009 is Atrial Fibrillation Month - Autocam Corporation
Autocam Completes Recapitalization; Positions the Companies for Growth - Bioscience
Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain - BIOTRONIK SE & Co. KG
New TRUST Trial Data Confirm Clinical Benefits of BIOTRONIK Home Monitoring(R) - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
